Venlafaxine for Hot Flashes After Breast Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2000
The purpose of this study is to evaluate Venlafaxine as a treatment option for hot flashes in breast cancer survivors. The goals of this study are to assess the effectiveness and toxicity of venlafaxine hydrochloride and identify the psychological, behavioral, and physical outcomes associated with relief of hot flashes in women following treatment for breast cancer.
Epistemonikos ID: 1222b0f1d7458bab8a89c653758c920a094174e7
First added on: May 04, 2024